Your browser doesn't support javascript.
loading
DNR order in SARS-CoV-2 patients: preliminary guidelines validation and quality of palliative care in a single Swiss COVID-19 Center.
Giorgia Lo Presti; Maira Biggiogero; Andrea Glotta; Carola Biondi; Zsofia Horvath; Rosambra Leo; Alessandra Franzetti-Pellanda; Andrea Saporito; Samuele Ceruti; Xavier Capdevila.
Afiliação
  • Giorgia Lo Presti; Ente Ospedaliero Cantonale
  • Maira Biggiogero; Clinica Luganese Moncucco
  • Andrea Glotta; Clinica Luganese Moncucco
  • Carola Biondi; Ente Ospedaliero Cantonale
  • Zsofia Horvath; Ente Ospedaliero Cantonale
  • Rosambra Leo; Ente Ospedaliero Cantonale
  • Alessandra Franzetti-Pellanda; Clinica Luganese Moncucco
  • Andrea Saporito; Ente Ospedaliero Cantonale
  • Samuele Ceruti; Clinica Luganese Moncucco
  • Xavier Capdevila; Hopital Universitaire de Montpellier
Preprint em En | PREPRINT-MEDRXIV | ID: ppmedrxiv-21260359
ABSTRACT
BackgroundThe worldwide pandemic situation forced many hospitals to adapt COVID-19 management strategies. In this scenario, the Swiss Academy of Medical Sciences (SAMW/ASSM) organized national guidelines based on expert opinion to identify Do-Not-Resuscitate (DNR) patients, to reduce futile ICU admission and resource misuse. However, the practical impact of this standardized national protocol has not been yet evaluated. In our specialized COVID-19 Center, we investigated characteristics and mortality of DNR patients identified according to national standardized protocol, comparing them to non-DNR patients. MethodsThis was a pilot retrospective validation study, evaluating consecutive hospital admitted COVID-19 patients. Primary outcome was 30-days survival of DNR patients in comparison to the control group. Secondary outcomes reported quality of treatment of deceased patients, especially of agitation/sedation and dyspnea, using respectively the Richmond Agitation-Sedation Scale - Palliative care (RASS-PAL) for sedation and agitation (+4/-5) and the modified Borg Scale for dyspnea (1-10). ResultsFrom March 16 to April 1, 2020, 213 consecutive patients were triaged; at 30-days follow-up, 9 patients (22.5%) died in the DNR group, 4 (2.2%) in the control group. The higher mortality rate in the DNR group was further confirmed by Log-Rank Mantel-Cox (23.104, p < 0.0001). In the DNR-group deceased patients, end-of-life support was performed with oxygen (100%), opioids (100%) and sedatives (89%); the mean RASS-PAL improved from 2.2 to -1.8 (p < 0.0001) and the Borg scale improved from 5.7 to 4.7 (p = 0.581). ConclusionA national standardized protocol identified patients at higher risk of short-term death. Although the legal status of DNRs varies from country to country, the implementation of national standardized protocol could be the way to guarantee a better treatment of COVID-19 patients in a pandemic situation with limited resources.
Licença
cc_no
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Cohort_studies / Experimental_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint
Texto completo: 1 Coleções: 09-preprints Base de dados: PREPRINT-MEDRXIV Tipo de estudo: Cohort_studies / Experimental_studies / Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Preprint